ATE350060T1 - Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten - Google Patents
Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthaltenInfo
- Publication number
- ATE350060T1 ATE350060T1 AT99938591T AT99938591T ATE350060T1 AT E350060 T1 ATE350060 T1 AT E350060T1 AT 99938591 T AT99938591 T AT 99938591T AT 99938591 T AT99938591 T AT 99938591T AT E350060 T1 ATE350060 T1 AT E350060T1
- Authority
- AT
- Austria
- Prior art keywords
- agents
- preventing
- active component
- receptor antibodies
- contain anti
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25179698 | 1998-08-24 | ||
| JP5430299 | 1999-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE350060T1 true ATE350060T1 (de) | 2007-01-15 |
Family
ID=26395047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99938591T ATE350060T1 (de) | 1998-08-24 | 1999-08-23 | Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8440196B1 (de) |
| EP (1) | EP1108435B1 (de) |
| JP (1) | JP4711507B2 (de) |
| AT (1) | ATE350060T1 (de) |
| AU (1) | AU757261B2 (de) |
| CA (1) | CA2341239C (de) |
| DE (1) | DE69934698T2 (de) |
| DK (1) | DK1108435T3 (de) |
| ES (1) | ES2276525T3 (de) |
| PT (1) | PT1108435E (de) |
| WO (1) | WO2000010607A1 (de) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU736282B2 (en) | 1997-03-21 | 2001-07-26 | Chugai Seiyaku Kabushiki Kaisha | A preventive or therapeutic agent for sensitized T cell- mediated diseases comprising IL-6 antagonist as an active ingredient |
| UA80091C2 (en) | 2001-04-02 | 2007-08-27 | Chugai Pharmaceutical Co Ltd | Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist |
| WO2003068260A1 (fr) | 2002-02-14 | 2003-08-21 | Chugai Seiyaku Kabushiki Kaisha | Produits pharmaceutiques en solution contenant des anticorps |
| GB2401040A (en) | 2003-04-28 | 2004-11-03 | Chugai Pharmaceutical Co Ltd | Method for treating interleukin-6 related diseases |
| CA2539061A1 (en) * | 2003-09-22 | 2005-03-31 | Biovation Gmbh & Co. Kg | Use of an antagonist of il-6 for treating il-6-mediated diseases |
| AR048335A1 (es) | 2004-03-24 | 2006-04-19 | Chugai Pharmaceutical Co Ltd | Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo |
| EP3269738A1 (de) | 2004-03-24 | 2018-01-17 | Chugai Seiyaku Kabushiki Kaisha | Subtypen des humanisiertem antikörper gegen interleukin-6-rezeptor |
| US8470316B2 (en) | 2005-10-14 | 2013-06-25 | Chugai Seiyaku Kabushiki Kaisha | Agents for suppressing damage to transplanted islets after islet transplantation |
| RU2450830C2 (ru) | 2005-10-21 | 2012-05-20 | Чугаи Сейяку Кабусики Кайся | Средства для лечения кардиопатии |
| AR057582A1 (es) | 2005-11-15 | 2007-12-05 | Nat Hospital Organization | Agentes para suprimir la induccion de linfocitos t citotoxicos |
| JP5033643B2 (ja) | 2006-01-27 | 2012-09-26 | 学校法人慶應義塾 | 脈絡膜血管新生を伴う疾患の治療剤 |
| JP5754875B2 (ja) | 2006-04-07 | 2015-07-29 | 国立大学法人大阪大学 | 筋再生促進剤 |
| US8080248B2 (en) | 2006-06-02 | 2011-12-20 | Regeneron Pharmaceuticals, Inc. | Method of treating rheumatoid arthritis with an IL-6R antibody |
| ATE537190T1 (de) | 2006-06-02 | 2011-12-15 | Regeneron Pharma | Hochaffine antikörper gegen den humanen il-6- rezeptor |
| WO2008019061A2 (en) | 2006-08-03 | 2008-02-14 | Vaccinex, Inc. | Anti-il-6 monoclonal antibodies and uses thereof |
| JP2010095445A (ja) * | 2006-12-27 | 2010-04-30 | Tokyo Medical & Dental Univ | Il−6アンタゴニストを有効成分とする炎症性筋疾患治療剤 |
| MX2009007830A (es) | 2007-01-23 | 2009-10-07 | Univ Shinshu | Inhibidor de rechazo cronico. |
| US9981415B2 (en) | 2007-09-10 | 2018-05-29 | Ehc Canada, Inc. | Method and apparatus for extrusion of thermoplastic handrail |
| PE20091174A1 (es) | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
| JP2011520898A (ja) | 2008-05-13 | 2011-07-21 | ノビミューン エスアー | 抗il−6/il−6r抗体およびそれらの使用方法 |
| TW201503898A (zh) | 2008-06-05 | 2015-02-01 | Chugai Pharmaceutical Co Ltd | 神經浸潤抑制劑 |
| US8188235B2 (en) | 2008-06-18 | 2012-05-29 | Pfizer Inc. | Antibodies to IL-6 and their uses |
| NZ617779A (en) | 2009-03-18 | 2015-08-28 | Resverlogix Corp | Novel anti-inflammatory agents |
| US9757368B2 (en) | 2009-04-22 | 2017-09-12 | Resverlogix Corp. | Anti-inflammatory agents |
| US20110117087A1 (en) | 2009-10-26 | 2011-05-19 | Reinhard Franze | Method for the production of a glycosylated immunoglobulin |
| JO3417B1 (ar) | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
| JP5904552B2 (ja) * | 2010-05-28 | 2016-04-13 | 国立研究開発法人国立がん研究センター | 膵癌治療剤 |
| RS63800B1 (sr) | 2010-05-28 | 2022-12-30 | Chugai Pharmaceutical Co Ltd | Poboljšanje antitumorskog odgovora t ćelije |
| KR101933197B1 (ko) | 2010-11-08 | 2018-12-27 | 제넨테크, 인크. | 피하 투여용 항―il―6 수용체 항체 |
| JPWO2012067150A1 (ja) * | 2010-11-16 | 2014-05-12 | 三菱化学株式会社 | Interleukin−6receptorsubunitbeta蛋白質による脳梗塞の検査方法 |
| TWI589299B (zh) | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
| JP6117915B2 (ja) | 2012-05-21 | 2017-04-19 | コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジーKorea Research Institute Of Bioscience And Biotechnology | ミゾコウジュの抽出物またはその分画物を有効成分として含む、stat3媒介性疾患の予防または治療用医薬組成物 |
| JP6563910B2 (ja) | 2013-07-04 | 2019-08-21 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ |
| US9017678B1 (en) | 2014-07-15 | 2015-04-28 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
| CN114984016A (zh) | 2015-03-13 | 2022-09-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
| EP3291980B1 (de) | 2015-05-07 | 2021-04-07 | EHC Canada, Inc. | Kompakte verbundstoffhandläufe mit verbesserten mechanischen eigenschaften |
| JP7128460B2 (ja) | 2015-06-04 | 2022-08-31 | 国立研究開発法人国立精神・神経医療研究センター | Il-6阻害剤を有効成分とする精神疾患治療剤 |
| RU2018101486A (ru) | 2015-06-19 | 2019-07-22 | ИЭйчСи Канада, Инк. | Способ и устройство для изготовления поручня из термопластичного полимера методом экструзии |
| US11484591B2 (en) | 2016-02-22 | 2022-11-01 | Ohio State Innovation Foundation | Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin A analogues or metabolites, and estradiol metabolites |
| WO2018112232A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible device |
| CA3045310A1 (en) | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
| WO2018112237A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-6r inhibitor |
| US11033496B2 (en) | 2017-03-17 | 2021-06-15 | The Regents Of The University Of Michigan | Nanoparticles for delivery of chemopreventive agents |
| CA3054632A1 (en) | 2017-03-30 | 2018-10-04 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
| EP3620531A4 (de) | 2017-05-02 | 2021-03-17 | National Center of Neurology and Psychiatry | Verfahren zur vorhersage und beurteilung der therapeutischen wirkung bei erkrankungen im zusammenhang mit il-6 und neutrophilen |
| WO2019078344A1 (ja) | 2017-10-20 | 2019-04-25 | 学校法人兵庫医科大学 | 抗il-6受容体抗体を含有する術後の癒着を抑制するための医薬組成物 |
| TWI822728B (zh) | 2018-01-31 | 2023-11-21 | 加藤元一 | 含有il-6抑制劑的哮喘治療劑 |
| US12227565B2 (en) | 2018-06-20 | 2025-02-18 | Biora Therapeutics, Inc. | Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine |
| US20230041197A1 (en) | 2018-06-20 | 2023-02-09 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
| WO2019246271A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor |
| JP7542543B2 (ja) | 2019-01-31 | 2024-08-30 | サノフィ・バイオテクノロジー | 若年性特発性関節炎を治療するための抗il-6受容体抗体 |
| WO2020201362A2 (en) | 2019-04-02 | 2020-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting and preventing cancer in patients having premalignant lesions |
| AU2020259884A1 (en) | 2019-04-17 | 2021-10-07 | Chugai Seiyaku Kabushiki Kaisha | Therapeutic agent for urological cancer which is characterized by being administered with il-6 inhibitor and ccr2 inhibitor in combination |
| JP2022545312A (ja) | 2019-04-24 | 2022-10-27 | サノフィ・バイオテクノロジー | 関節リウマチの診断及び処置の方法 |
| CA3142710A1 (en) | 2019-06-04 | 2020-12-10 | Sanofi Biotechnology | Compositions and methods for treating pain in subjects with rheumatoid arthritis |
| AU2021274836A1 (en) | 2020-05-19 | 2023-01-05 | Aarhus Universitet | Lysm receptor motifs |
| WO2024126805A1 (en) | 2022-12-15 | 2024-06-20 | Aarhus Universitet | Synthetic activation of multimeric transmembrane receptors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2898040B2 (ja) | 1990-01-26 | 1999-05-31 | 忠三 岸本 | gp130蛋白質に対する抗体 |
| US5210075A (en) * | 1990-02-16 | 1993-05-11 | Tanabe Seiyaku Co., Ltd. | Interleukin 6 antagonist peptides |
| AU668349B2 (en) * | 1991-04-25 | 1996-05-02 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin 6 receptor |
| JPH05304986A (ja) | 1992-04-28 | 1993-11-19 | Tosoh Corp | gp130蛋白質に対するモノクロ−ナル抗体 |
| JP3525221B2 (ja) * | 1993-02-17 | 2004-05-10 | 味の素株式会社 | 免疫抑制剤 |
| PL182089B1 (en) * | 1994-10-21 | 2001-11-30 | Chugai Pharmaceutical Co Ltd | Pharmaceutic compositions for treating diseases caused by production of il-6 |
| IT1274350B (it) | 1994-12-06 | 1997-07-17 | Angeletti P Ist Richerche Bio | Antagonisti di interleuchina-6(il-6) che consistono di forme solubili del ricettore alfa di il-6, mutate nell'interfaccia che si lega a gp 130 |
| IT1274782B (it) | 1994-12-14 | 1997-07-24 | Angeletti P Ist Richerche Bio | Metodo per selezionare superagonisti, antagonisti e superantagonisti di ormoni del cui complesso recettoriale fa parte gp 130 |
| AU6038196A (en) | 1995-06-07 | 1996-12-30 | Private Biologicals Corporation | Compositions and methods of treating il-6 associated disease s |
-
1999
- 1999-08-23 CA CA2341239A patent/CA2341239C/en not_active Expired - Fee Related
- 1999-08-23 DK DK99938591T patent/DK1108435T3/da active
- 1999-08-23 ES ES99938591T patent/ES2276525T3/es not_active Expired - Lifetime
- 1999-08-23 PT PT99938591T patent/PT1108435E/pt unknown
- 1999-08-23 JP JP2000565927A patent/JP4711507B2/ja not_active Expired - Fee Related
- 1999-08-23 WO PCT/JP1999/004533 patent/WO2000010607A1/ja not_active Ceased
- 1999-08-23 AU AU53049/99A patent/AU757261B2/en not_active Ceased
- 1999-08-23 EP EP99938591A patent/EP1108435B1/de not_active Expired - Lifetime
- 1999-08-23 US US09/762,550 patent/US8440196B1/en not_active Expired - Fee Related
- 1999-08-23 DE DE69934698T patent/DE69934698T2/de not_active Expired - Lifetime
- 1999-08-23 AT AT99938591T patent/ATE350060T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69934698D1 (de) | 2007-02-15 |
| AU757261B2 (en) | 2003-02-13 |
| CA2341239A1 (en) | 2000-03-02 |
| US8440196B1 (en) | 2013-05-14 |
| AU5304999A (en) | 2000-03-14 |
| CA2341239C (en) | 2011-01-04 |
| WO2000010607A1 (en) | 2000-03-02 |
| DE69934698T2 (de) | 2007-10-04 |
| DK1108435T3 (da) | 2007-02-05 |
| ES2276525T3 (es) | 2007-06-16 |
| EP1108435A1 (de) | 2001-06-20 |
| JP4711507B2 (ja) | 2011-06-29 |
| EP1108435A4 (de) | 2002-05-08 |
| EP1108435B1 (de) | 2007-01-03 |
| PT1108435E (pt) | 2007-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69934698D1 (de) | Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten | |
| ATE387215T1 (de) | Mittel zur prävention oder behandlung von psoriasis mit einem il-6-antagonist als wirkstoff | |
| DE69839992D1 (de) | Vorbeugende- oder Heilmittel zur Behandlung von Multipler Sklerose, mit antagonistischen anti-IL6-Rezeptor Antikörpern als Wirkstoff | |
| EP1074268A4 (de) | Prophylaktische oder therapeutische mittel gegen entzündliche erkrankungen des verdauungstraktes mit il-6 antagonisten als aktiven inhaltsstoffen | |
| TR200002965T2 (tr) | Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı | |
| NO971546D0 (no) | Reumatoid artritt-middel inneholdende IL-6-antagonist som aktiv bestanddel | |
| ATE218854T1 (de) | Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase | |
| ATE123943T1 (de) | Mittel zur behandlung und vorbeugung von bauchentzündungen, die als wirkstoff zink-l- carnosin-salze oder -komplexe enthalten. | |
| BR0107942A (pt) | Polìmeros de proteìna de liberação lenta | |
| ATE301994T1 (de) | Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda- antagonist | |
| DE69829558D1 (de) | Sulfonamide für die behandlung von störungen durch endothelin vermittelt | |
| ES2170815T3 (es) | Potenciador de agente antitumoral que comprende un antagonista de il-6. | |
| DE69713485D1 (de) | Medikamente für die Behandlung oder Vorbeugung von Thrombocytopenie | |
| DE69307617D1 (de) | Verwendung von Kompetitiven NMDA-Rezeptorantagonisten zur Behandlung der Harninkontinenz | |
| DE50011178D1 (de) | Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen | |
| ATE346867T1 (de) | Rekombinante il-5 antagonisten für die behandlung von il-5 bedingten krankheiten | |
| ATE332145T1 (de) | Arzneien zur begleitenden behandlung von glaukomen | |
| ES2136252T3 (es) | Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa. | |
| DE60210101D1 (de) | Behandlung von haarfollikeln mit neurokinin 1 rezeptor antagonisten | |
| DE69731658D1 (de) | Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen | |
| DK1169058T3 (da) | Insulinlignende vækstfaktorbindingsprotein-4-protease | |
| ATE277924T1 (de) | Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression | |
| ATE282416T1 (de) | Die verwendung von nk-1 rezeptor antagonisten für die behandlung von substanz-verwendung störungen | |
| DE69426986D1 (de) | Behandlung von laminitis | |
| DE69935662D1 (de) | Mittel zur prävention/behandlung entzündlicher darmerkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1108435 Country of ref document: EP |